QuidelOrtho
Brian Blaser said the firm has eliminated certain C-suite positions and implemented strategies to improve the firms profitability.
Preliminary Earnings Roundup: Natera, Guardant Health, Exact Sciences, CareDx, GeneDx, More
Several molecular diagnostics firms reported fourth quarter and full-year 2024 revenues and other business updates ahead of the annual JP Morgan Healthcare Conference this week.
People in the News at Danaher, QuidelOrtho, Myriad Genetics, Hologic, Pacific Biosciences, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
Jefferies Initiates Coverage of NeoGenomics, Hologic, QuidelOrtho
The investment bank said it prefers diagnostics companies with strong commercial engines, although noted it that Hologic and QuidelOrtho are in transition.
In Brief This Week: Revvity, Genomics England, CeGaT, Cmbio, Parse Biosciences, Bruker, More
News items for the week of Nov. 18, 2024.
Sep 5, 2024
Craig-Hallum Upgrades QuidelOrtho to Buy
Mar 6, 2024
Mar 4, 2024
UBS Downgrades QuidelOrtho to Sell
Feb 21, 2024
QuidelOrtho Parts Ways With Longtime CEO Doug Bryant
Jan 16, 2024
Aug 9, 2023